ATE309353T1 - Verfahren zur herstellung von rekombinanten peptiden - Google Patents

Verfahren zur herstellung von rekombinanten peptiden

Info

Publication number
ATE309353T1
ATE309353T1 AT00916489T AT00916489T ATE309353T1 AT E309353 T1 ATE309353 T1 AT E309353T1 AT 00916489 T AT00916489 T AT 00916489T AT 00916489 T AT00916489 T AT 00916489T AT E309353 T1 ATE309353 T1 AT E309353T1
Authority
AT
Austria
Prior art keywords
recombinant peptides
producing recombinant
peptides
production
present
Prior art date
Application number
AT00916489T
Other languages
English (en)
Inventor
Marc D Better
Patrick D Gavit
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Application granted granted Critical
Publication of ATE309353T1 publication Critical patent/ATE309353T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT00916489T 1999-03-18 2000-03-17 Verfahren zur herstellung von rekombinanten peptiden ATE309353T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/271,970 US6242219B1 (en) 1999-03-18 1999-03-18 Methods for recombinant peptide production
PCT/US2000/007148 WO2000055322A1 (en) 1999-03-18 2000-03-17 Improved methods for recombinant peptide production

Publications (1)

Publication Number Publication Date
ATE309353T1 true ATE309353T1 (de) 2005-11-15

Family

ID=23037863

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00916489T ATE309353T1 (de) 1999-03-18 2000-03-17 Verfahren zur herstellung von rekombinanten peptiden

Country Status (10)

Country Link
US (4) US6242219B1 (de)
EP (1) EP1165782B1 (de)
JP (1) JP2002538824A (de)
AT (1) ATE309353T1 (de)
AU (1) AU782359B2 (de)
CA (1) CA2365697C (de)
DE (1) DE60023860T2 (de)
ES (1) ES2253212T3 (de)
NZ (1) NZ514230A (de)
WO (1) WO2000055322A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754211B2 (en) * 1992-04-10 2010-07-13 Research Development Foundation Immunotoxins directed against c-erbB-2(HER-2/neu) related surface antigens
US6946261B1 (en) 1998-11-20 2005-09-20 Migenix Inc. Efficient methods for producing anti-microbial cationic peptides in host cells
US6242219B1 (en) * 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production
US20030219854A1 (en) * 2002-03-21 2003-11-27 Micrologix Biotech Inc. Methods for producing modified anti-infective peptides
WO2003089455A2 (en) * 2002-04-22 2003-10-30 Dow Global Technologies Inc. Low-cost production of peptides
BR0316232A (pt) * 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo
US7736633B2 (en) * 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
US20100234568A1 (en) * 2006-10-19 2010-09-16 Linda Jane Decarolis Identification of peptide tags for the production of insoluble peptides by sequence scanning
US7662913B2 (en) 2006-10-19 2010-02-16 E. I. Du Pont De Nemours And Company Cystatin-based peptide tags for the expression and purification of bioactive peptides
US7732569B2 (en) 2006-10-19 2010-06-08 E.I. Du Pont De Nemours And Company Zein-based peptide tags for the expression and purification of bioactive peptides
US7678883B2 (en) * 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
US9062312B2 (en) 2011-06-21 2015-06-23 Danisco Us Inc. Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications
US9115182B2 (en) 2011-06-21 2015-08-25 E I Du Pont De Nemours And Company Cysteine cross-linked structural peptides
EP2792686A1 (de) 2013-04-17 2014-10-22 Heinrich-Heine-Universität Düsseldorf Verfahren zur Expression von Peptiden und Proteinen
JP6817939B2 (ja) 2014-12-01 2021-01-20 フェネックス インク． ペプチド産生のための融合パートナー
US10538596B2 (en) 2015-01-09 2020-01-21 Adalta Limited CXCR4 binding molecules and methods of use thereof
EP4444739A2 (de) 2021-12-08 2024-10-16 Oakgrove Bio LLC Biologische herstellung von histidinreichen peptiden

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2933704A1 (de) 1979-08-21 1981-03-26 Festo Kg, 73734 Esslingen Druckmittelverbindung zwischen einem ventilblock und einem zumindest einen doppelt wirkenden druckmittelmotor aufweisenden verbraucher
US5206154A (en) 1985-01-28 1993-04-27 Xoma Corporation Method of producing cecropins by microbiological techniques
AU6104786A (en) * 1985-08-12 1987-02-19 Syntex (U.S.A.) Inc. Fusion proteins using trple gene
US5416007A (en) * 1987-03-20 1995-05-16 Creative Biomolecules, Inc. Enhanced proteolytic cleavage of recombinant fusion proteins
US4958007A (en) * 1988-05-17 1990-09-18 Schering-Plough Corp. Extraction of human interleukin-4- from bacteria
IT1226551B (it) * 1988-07-29 1991-01-24 Sclavo Spa Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
US5376546A (en) 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5621083A (en) 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5837491A (en) 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
DE69332740T2 (de) 1992-08-21 2004-02-05 The University Of British Columbia, Vancouver Kationische peptide und verfahren zu deren herstellung
US5789377A (en) 1992-08-21 1998-08-04 University Of British Columbia Treatment of endotoxin-associated disorders with cationic peptides
US5593866A (en) 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US5420019A (en) 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
AU3909893A (en) 1993-03-04 1994-09-26 Dmitry Nikolaevich Motovilov Secondary electrical power source based on motovilov transformers
US5733872A (en) 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5652332A (en) 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
ES2123134T3 (es) 1993-03-12 1999-01-01 Xoma Corp Peptidos biologicamente activos de dominios funcionales de la proteina bactericida aumentadora de la permeabilidad y usos de los mismos.
US5348942A (en) 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
ES2157981T3 (es) 1993-03-12 2001-09-01 Xoma Technology Ltd Usos terapeuticos de productos proteicos bactericidas/aumentadores de la permeabilidad.
EP0824547B1 (de) 1994-09-15 2003-12-10 XOMA Technology Ltd. Peptide gegen pilzen
WO1997004008A1 (en) 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
US5851802A (en) 1996-03-22 1998-12-22 Xoma Corporation Methods for recombinant microbial production of fusion proteins and BPI-derived peptides
US6242219B1 (en) * 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production

Also Published As

Publication number Publication date
US20030194782A1 (en) 2003-10-16
EP1165782B1 (de) 2005-11-09
US20090246831A1 (en) 2009-10-01
JP2002538824A (ja) 2002-11-19
ES2253212T3 (es) 2006-06-01
US20020009781A1 (en) 2002-01-24
US6242219B1 (en) 2001-06-05
AU3758700A (en) 2000-10-04
US7749731B2 (en) 2010-07-06
AU782359B2 (en) 2005-07-21
WO2000055322A1 (en) 2000-09-21
CA2365697C (en) 2007-01-09
US6500648B1 (en) 2002-12-31
DE60023860D1 (de) 2005-12-15
CA2365697A1 (en) 2000-09-21
US7247454B2 (en) 2007-07-24
NZ514230A (en) 2004-01-30
EP1165782A1 (de) 2002-01-02
DE60023860T2 (de) 2006-08-03

Similar Documents

Publication Publication Date Title
ATE309353T1 (de) Verfahren zur herstellung von rekombinanten peptiden
DE69731834D1 (de) Agouti verwandtes gen
ATE410441T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
DE69739996D1 (de) Methoden und Zusammensetzungen zur Herstellung von Polypeptiden
DE60033553D1 (de) Verfahren zur herstellung von tripeptiden
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
DE69933207D1 (de) Verbessertes verfahren zur herstellung von makroliden
DE59907055D1 (de) Verfahren zur herstellung von tetrachlorkohlenstoffarmen phosgen
ATE344273T1 (de) Verfahren zur herstellung von 21-hydroxy-6,19- oxidoprogesteron (21oh-6op)
DE69709655D1 (de) Verfahren zur herstellung von 17-estern von 9alpha,21-dihalopregan-11beta,17alpha-diol-20-onen
DE69725580D1 (de) Prozess zur herstellung von aza zyclohexapeptide
ATE531724T1 (de) Verfahren zur herstellung von peptiden
ATE227307T1 (de) Verfahren zur herstellung modifizierten proteine
DE60039688D1 (de) Verfahren zur herstellung von uhrarmbandteilen
DE60309847D1 (de) Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
ATE204023T1 (de) Enzymatische verfahren zur herstellung von (s)- cyanhydrinen
DE19983485T1 (de) Verfahren zur Herstellung von Gasfedern
DE60044900D1 (de) Ein verbessertes verfahren zur herstellung von alkylpolyglycosiden
ATE239695T1 (de) Stereoselektive verfahren zur herstellung von gabapentinanalogen
DK0977859T3 (da) Den neurotrofiske faktor NNT-1
DE50008921D1 (de) Verfahren zur herstellung von blockweichschaumpolyolen
DE60043559D1 (de) Verfahren zur Herstellung von Elektroden
DE50103009D1 (de) Verfahren zur herstellung von 2-alkyl-3-chlorphenolen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165782

Country of ref document: EP

REN Ceased due to non-payment of the annual fee